As of Jan 20
| -0.30 / -4.56%|
The 4 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 12.50, with a high estimate of 13.00 and a low estimate of 11.00. The median estimate represents a +99.04% increase from the last price of 6.28.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.